Alnylam Pharmaceuticals
ALNY
#788
Rank
NZ$55.47 B
Marketcap
NZ$414.61
Share price
3.63%
Change (1 day)
-48.47%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company